[HTML][HTML] A critical overview of targeted therapies for vestibular schwannoma
R Tamura, M Toda - International journal of molecular sciences, 2022 - mdpi.com
Vestibular schwannoma (VS) is a benign tumor that originates from Schwann cells in the
vestibular component. Surgical treatment for VS has gradually declined over the past few …
vestibular component. Surgical treatment for VS has gradually declined over the past few …
YAP and TAZ: monocorial and bicorial transcriptional co-activators in human cancers
FL Sardo, V Canu, M Maugeri-Saccà, S Strano… - … et Biophysica Acta (BBA …, 2022 - Elsevier
The transcriptional regulators YAP and TAZ are involved in numerous physiological
processes including organ development, growth, immunity and tissue regeneration. YAP …
processes including organ development, growth, immunity and tissue regeneration. YAP …
Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma
L Laraba, L Hillson, JG De Guibert, A Hewitt… - Brain, 2023 - academic.oup.com
Schwannoma tumours typically arise on the eighth cranial nerve and are mostly caused by
loss of the tumour suppressor Merlin (NF2). There are no approved chemotherapies for …
loss of the tumour suppressor Merlin (NF2). There are no approved chemotherapies for …
[HTML][HTML] Hippo pathway in Schwann cells and regeneration of peripheral nervous system
J Wang, H Chen, W Hou, Q Han, Z Wang - Developmental …, 2023 - karger.com
Hippo pathway is an evolutionarily conserved signaling pathway comprising a series of
MST/LATS kinase complexes. Its key transcriptional coactivators YAP and TAZ regulate …
MST/LATS kinase complexes. Its key transcriptional coactivators YAP and TAZ regulate …
[HTML][HTML] The Hippo signaling pathway in leukemia: function, interaction, and carcinogenesis
N Noorbakhsh, B Hayatmoghadam, M Jamali… - Cancer cell …, 2021 - Springer
Cancer can be considered as a communication disease between and within cells;
nevertheless, there is no effective therapy for the condition, and this disease is typically …
nevertheless, there is no effective therapy for the condition, and this disease is typically …
The Hippo pathway: Horizons for innovative treatments of peripheral nerve diseases
Initially identified in Drosophila, the Hippo signaling pathway regulates how cells respond to
their environment by controlling proliferation, migration and differentiation. Many recent …
their environment by controlling proliferation, migration and differentiation. Many recent …
[HTML][HTML] Targeted STAT1 therapy for LZTR1‐driven peripheral nerve sheath tumor
T Ivanisevic, M Steklov, B Lechat… - Cancer …, 2023 - ncbi.nlm.nih.gov
Dear Editor, Schwannomas are peripheral nervous system tumors that cause chronic pain,
numbness, and potentially lifethreatening organ dysfunction. Surgery is a conventional …
numbness, and potentially lifethreatening organ dysfunction. Surgery is a conventional …
[HTML][HTML] Transcriptional modulation of the hippo signaling pathway by drugs used to treat bipolar disorder and schizophrenia
B Panizzutti, CC Bortolasci, B Spolding… - International Journal of …, 2021 - mdpi.com
Recent reports suggest a link between positive regulation of the Hippo pathway with bipolar
disorder (BD), and the Hippo pathway is known to interact with multiple other signaling …
disorder (BD), and the Hippo pathway is known to interact with multiple other signaling …
Systematic Characterization of the Clinical and Pathological Features of Schwannomas Harboring SH3PXD2A:: HTRA1 Fusion
JC Lee, PH Lee, SC Li, KC Liao, YM Chang, HC Chen… - Modern Pathology, 2024 - Elsevier
The understanding of schwannoma tumorigenesis has been reshaped by the recent
identification of SH3PXD2A:: HTRA1 fusion in 10% of intracranial/spinal schwannomas …
identification of SH3PXD2A:: HTRA1 fusion in 10% of intracranial/spinal schwannomas …
Merlin cooperates with neurofibromin and Spred1 to suppress the Ras–Erk pathway
Y Cui, L Ma, S Schacke, JC Yin… - Human Molecular …, 2020 - academic.oup.com
Abstract The Ras–Erk pathway is frequently overactivated in human tumors.
Neurofibromatosis types 1 and 2 (NF1, NF2) are characterized by multiple tumors of …
Neurofibromatosis types 1 and 2 (NF1, NF2) are characterized by multiple tumors of …